Merck KGaA Website

Merck KGaA

XTRA-MRK

Basic

  • Market Cap

    €66.33B

  • EV

    €73.87B

  • Shares Out

    434.78M

  • Revenue

    €20.82B

  • Employees

    62,345

Margins

  • Gross

    58.23%

  • EBITDA

    24.59%

  • Operating

    17.25%

  • Pre-Tax

    16.19%

  • Net

    13.07%

  • FCF

    10.61%

Returns (5Yr Avg)

  • ROA

    6.05%

  • ROTA

    20.98%

  • ROE

    12.9%

  • ROCE

    10.6%

  • ROIC

    6.89%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €181.44

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €2,484M

  • Net Debt

    €7,470M

  • Debt/Equity

    0.35

  • EBIT/Interest

    13.35

Growth (CAGR)

  • Rev 3Yr

    5.37%

  • Rev 5Yr

    6.64%

  • Rev 10Yr

    6.62%

  • Dil EPS 3Yr

    6.11%

  • Dil EPS 5Yr

    -3.29%

  • Dil EPS 10Yr

    7.96%

  • Rev Fwd 2Yr

    3.64%

  • EBITDA Fwd 2Yr

    6.66%

  • EPS Fwd 2Yr

    8.65%

  • EPS LT Growth Est

    8.16%

Dividends

  • Yield

  • Payout

    35.12%

  • DPS

    €2.2

  • DPS Growth 3Yr

    16.26%

  • DPS Growth 5Yr

    11.97%

  • DPS Growth 10Yr

    8.76%

  • DPS Growth Fwd 2Yr

    7.68%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

16,152

17,534

19,687

22,232

20,993

20,820

Total Revenues % Chg.

8.9%

8.6%

12.3%

12.9%

-5.6%

-6.7%

Cost of Goods Sold, Total

5,951

6,782

7,325

8,500

8,558

8,696

Gross Profit

10,201

10,752

12,362

13,732

12,435

12,124

Selling General & Admin Expenses, Total

5,683

5,295

5,458

5,989

5,784

5,736

Stock-Based Compensation

-14

5

3

-7

2

2

R&D Expenses

2,239

2,262

2,418

2,447

2,439

2,423

Other Operating Expenses

-260

119

177

325

515

372

Other Operating Expenses, Total

7,648

7,681

8,056

8,754

8,740

8,533

Operating Income

2,553

3,071

4,306

4,978

3,695

3,591

Interest Expense, Total

-403

-328

-245

-196

-260

-269

Interest And Investment Income

66

39

46

71

172

172

Net Interest Expenses

-337

-289

-199

-125

-88

-97

Currency Exchange Gains (Loss)

-86

-60

-34

-109

51

51

Other Non Operating Income (Expenses)

-1

2

14

-3

26

25

EBT, Excl. Unusual Items

2,129

2,724

4,087

4,741

3,684

3,570

Restructuring Charges

-123

-170

-82

-199

-248

-248

Merger & Related Restructuring Charges

-217

-190

-59

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

30

94

63

45

132

132

Asset Writedown

-42

-183

-54

-232

-98

-98

Legal Settlements

-42

372

8

-6

-1

-1

Other Unusual Items

-16

-39

-61

15

15

EBT, Incl. Unusual Items

1,735

2,631

3,924

4,288

3,484

3,370

Income Tax Expense

440

637

859

948

650

637

Earnings From Continuing Operations

1,295

1,994

3,065

3,340

2,834

2,733

Earnings Of Discontinued Operations

28

Minority Interest

-3

-7

-10

-14

-10

-11

Net Income

1,320

1,987

3,055

3,326

2,824

2,722

Net Income to Common Incl Extra Items

1,320

1,987

3,055

3,326

2,824

2,722

Net Income to Common Excl. Extra Items

1,292

1,987

3,055

3,326

2,824

2,722

Total Shares Outstanding

434.8

434.8

434.8

434.8

434.8

433.7

Weighted Avg. Shares Outstanding

434.8

434.8

434.8

434.8

434.8

434.5

Weighted Avg. Shares Outstanding Dil

434.8

434.8

434.8

434.8

434.8

434.5

EPS

3

4.6

7

7.6

6.5

6.3

EPS Diluted

3

4.6

7

7.6

6.5

6.3

EBITDA

4,234

4,591

5,788

6,522

5,226

5,120

Effective Tax Rate

25.4%

24.2%

21.9%

22.1%

18.7%

18.9%